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TECHNICAL NOTE
Nephrotoxic canine glomerulonephritis
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Extensive literature and laboratory experience have
accumulated using the dog as a model animal for the
study of normal and pathophysiological states.
Relatively little investigation has been made, how-
ever, using dogs who are the subjects of diffuse,
parenchymal disease, particularly glomerulonephritis.
We undertook to study nephrotoxic (antiglomerular
basement membrane [GBM] antibody) nephritis in the
dog [1—3]; the focus of our interest was immunologic:
to establish in the dog 1) the validity of nephrotoxic
nephritis data acquired in other species, particularly
rabbits, rats and sheep; 2) the quantitative basis of
the experimental model; and 3) the predictability of
induction of disease.
Limited experiments using active immunization did
not establish sufficient renal disease for useful, subse-
quent laboratory manipulation. Passive immunization
of dogs, however, using rabbit and sheep anticanine
GBM sera predictably caused acute and persistent
glomerulonephritis. As in other species examined [4],
passive canine nephrotoxic glomerulonephritis com-
prised heterologous and autologous immunologic
components and had a dose-dependent requirement
for initial injury. Moreover, the persistence of hetero-
logous antibodies fixed to host GBM makes it possible
to manipulate the extent of injury repeatedly during
serial studies.
Methods
Adult outbred mongrel dogs, 2.2 to 14.0 kg in
weight, were used in these experiments. Routine blood
chemistry determinations were performed on an
autoanalyzer (Technicon); urinary protein concen-
trations were determined using sulfosalicyclic acid;
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protein nitrogen was analyzed by micro-Kjeldahl
procedures. Complement titrations (C'50H) were
performed on freshly drawn canine serum clotted for
one hour at room temperature and stored at —70°C.
Isotopic techniques included the radiolabelling of serum
proteins with 131J or 1251 by the method of McConahey
and Dixon [5]. Kidney-fixing antibodies (KFab) were
measured by injecting into dogs nephrotoxic globulin
(NTG) labelled with 125J or 181J concomitant with
normal sheep globulin labelled with the alternate
isotope; percent of KFab was calculated as described
by Lerner and Dixon [6]. Immune elimination studies
were conducted by daily counting of 1 ml of blood
from animals injected with l0 (dpm) of labelled
normal or nephrotoxic sheep globulin. Immuno-
fluorescent (IF) microscopy was done by the tech-
nique of Coons and Kaplan [7]; controls have been
described previously [8].
Antigens. Canine and human GBM were prepared
by the technique of Krakower and Greenspon [9].
Sheep, rabbit and canine IgG were prepared by salting
out with ammonium sulfate, followed by diethyl-
aminoethyl (DEAE) cellulose chromatography [8];
lots of sheep, rabbit and canine albumin were isolated
by preparative electrophoresis on Pevikon after initial
globulin precipitation. Antisera to rabbit, sheep and
canine IgG and albumin were prepared in rabbits or
sheep as described previously [8]. Specificity of anti-
sheep and canine IgG sera was assured by absorption
with canine and sheep globulin, respectively; sera
subsequently were tested by double diffusion in
agarose, by immunoelectrophoresis (IEP) and by
blocking experiments of the fluoresceinated antisera
on known positive targets. Antiserum to third com-
ponent of canine serum complement (C'3, 1C) was
prepared by the technique of Mardiney and Muller-
Eberhard [10]; another antiserum to canine C'3 was
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obtained commercially (Cappel Laboratories, Inc.,
Downingtown, PA). Fluoresceinated reagents were
prepared by dialysis.
Nephro toxic sera were prepared in sheep and rabbits
immunized with particulate canine GBM, 50 mg in
Freund's complete adjuvant (CFA) subcutaneously at
monthly intervals. Sera were harvested by bleeding
ten days after booster injections, heat-inactivated,
absorbed three times with equal volumes of pooled,
packed, washed canine red blood cells, tested by
hemagglutination and fractionated with ammonium
sulfate. Nephrotoxic globulin (NTG) was assayed by
indirect IF for anticanine GBM antibody titers using
normal canine kidney substrate. The KFab content of
pools was measured directly as described above.
Prior to use, NTG was absorbed further with red
blood cells of the intended canine recipient and ad-
ministered i.v. in one dose to experimental animals.
Active immunization of normal dogs with human or
canine GBM. Four dogs received 50 mg of particulate
canine GBM in CFA subcutaneously every three
weeks; four other dogs received 50 mg of particulate
human GBM in CFA similarly. They were biopsied
after six weeks and sacrificed at six months.
Passive immunization experiments with NTG (Table
1). A) Dose-response studies of immediate (heterolo-
gous phase) and/or late (autologous phase) proteinuria
were performed in six dogs using 5 to 1000 g of
KFab/kg of body wt. B) Samples of sheep and rabbit
NTG of comparable KFab content were tested for
nephritogenic potency. C) Clinical glomerulonephritis
was induced in four dogs over a tenfold range of
KFab in excess of that adequate to induce immediate
proteinuria. D, E, F) Whole serum C' titrations and
renal fixation of canine C'3 were tested in six animals
over a fivefold range of KFab to examine the dose
impact on in vivo C' fixation in heterologous and
autologous phases of disease; in experiment F, im-
mune elimination of radiolabelled NTG was also
tested. G) To test the possibility of persistent fixation
of heterologous KFab, two dogs whose autologous
proteinuria had waned were challenged with tenfold
differing doses of antisheep IgG 4+ months after
initial passive immunization. H) Two other dogs
initially immunized with tenfold differing amounts of
KFab were challenged with small doses of heterologous
antiglobulin four months later. With the exception of
experiment B, all NTG was harvested from sheep.
Passive immunization control experiments. A) Six
normal dogs were biopsied. B) Antigen elimination
of normal sheep globulin was determined (50 mg/kg of
body wt). C) Six dogs were administered 500 mg/kg of
body wt of normal sheep globulin i.v., and biopsied on
day 18.
Results
Active immunization. Dogs immunized actively with
human GBM developed proteinuria ranging from
100 to 460 mg daily (average, 323 mg) at time of
sacrifice. They had linear fixation of host IgG on
glomeruli and focal areas of tubular basement mem-
branes on biopsy six weeks and six months after
initial immunization. In contrast, dogs immunized
Table 1. Passive immunization experiments with nephrotoxic globulin (NTG)
Experiment Dogs,N Dose, gof KFab/kg
of body wt
Serum
pool
Experimental day
biopsied
Dose, mg of
antisheep IgG
Day second
antibody given
A Dose-response 2
2
2
5
50
1.000
SH-3
SH-3
SH-3
10, 30, 60
10, 30, 60
10, 30, 60
B Comparison of sheep and 1 700 SH-1 10, 24
rabbit NTG 1 750 R-1 10, 24
C Induction of glomerulonephritis
D In vivo C' fixation; low dose
1
1
2
2
1,250
12,250
3,000
1,400
SH-4
SH-4
SH-5
SH-6
10, 28
2
10, 28
3, 14
NTG
E In vivo C' fixation; high dose 2 6,800 SH-6 3 hr
NTU 24hr
F Antigen-elimination 2 2,700 SH-6 24
G Rechallenge with rabbit 1 2,700 SH-6 145 3.1 141
anti-SH Ig 1 2,700 SH-6 145 31.0 141
H Rechallenge with rabbit 1 270 SH-6 130 3.1 123
anti-SH IgG 1 2,700 SH-6 130 3.1 123
KFab, kidney fixing antibody.
Nephrotoxic canine glomerulonephritis 125
with homologous GBM did not develop detectable
glomerular fixation of host Ig; proteinuria ranged
from 48 to 155 mg daily at time of sacrifice (average,
121 mg). Blood urea nitrogen (BUN) and serum
creatinine concentrations remained normal in all
animals.
Passive immunization with NTG. A) At doses of 5 to
1000 ig of KFab/kg of body wt, all dogs had detectable
fixation of sheep IgG in a linear pattern of GBM with
intensity proportional to amounts given. Only the
two animals receiving 1000mg of KFab/kg of body wt
developed immediate proteinuria (0.5 and 1.4 g ex-
creted in initial 24 hr); delayed proteinuria occurred
(day 7 and following) in dogs receiving 50 and
1000 mg/kg, but not in animals receiving 5 mg/kg
of body wt. Biopsy specimens at 10, 30 and 60 days
showed fixation of host and heterologous IgG to
GBM (Figs. 1 and 2). BUN and serum creatinine con-
centrations remained normal in all dogs. B) NTG
from sheep and rabbit pools at comparable concen-
trations (700, 750 mg/kg of body wt of KFab) caused
immediate proteinuria (3.9 and 2.0 g in initial 24 hr),
as well as delayed proteinuria which developed in a
biphasic manner characteristic of autologous response
to donor nephrotoxic 1g. Biopsy specimens taken at
10 and 24 days showed heavy linear deposition of host
and heterologous Ig along GBM; BUN values
peaked in the dogs at 31 to 58 mg/100 ml at day 15. C)
NTG given to four dogs in doses of 1.25, 3.0 and
12.5 mg/kg of body wt induced immediate proteinuria
in all (1.5 to 15.5 g in initial 24 hr); the two dogs re-
Fig. 1. Typical linear staining of heterolo-
gous (sheep) nephrotoxic IgG on glomeru-
his ofdogat ten days; experiment A: dog
received 1 mg of kidney-fixing antibody
(KFab)/kg of body wt (x 350).
ceiving 3.0 mg/kg of body wt had sustained proteinuria,
chemical nephrotic syndrome and BUN concentrations
ranging up to 136 mg/i 00 ml by day 10. The dog
given 12.5 mg/kg of body wt died after 48 hr with heavy
proteinuria and azotemia (BUN value, 80 mg/lOO ml).
D) Biopsy specimens on the third day after dogs re-
ceived 1.4 mg/kg of body wt of KFab revealed heavy
sheep IgG fixation to canine GBM and faint fixation
of host B1C, without host 1g. In contrast, biopsy
specimens at day 14 showed heavy staining of hetero-
logous Ig, and host Ig and B1C. E) To test the quanti-
tative effects of NTG on early fixation of host B1C at
sites of antibody binding, 6.8 mg/kg of body wt of KFab
was given to dogs biopsied after 3 and 24 hr; direct
IF revealed faint fixation of host B1C at 3 hr, which
increased in intensity by 24 hr. C'50H values (Table 2)
indicated that serum C' values are stable in animals
receiving low and moderate amounts of NTG until
experimental day 7, when host autologous response to
donor proteins is apparent and immune elimination
has begun. F) Elimination of isotopically labelled
NTG and normal sheep globulins was completed
between experimental days 10 and 12 in three separate
experiments; the results accord well with fall in
serum C'50H values, detection of host Ig on hetero-
logous NTG along GBM and detection of precipitat-
ing antibodies to sheep IgG in host circulation.
G, H) Heterologous doses of 0.270 or 2.7 mg/kg of
body wt of KFab were given to four dogs; the smaller
dose induced only delayed proteinuria, while the larger
dose caused immediate and delayed proteinuria. Four
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Fig. 2. Same animal as in Fig. 1: shows
focal tubular basement membrane staining
seen in animals receiving nephrotoxic anti-
body (staining for heterologous !gG
[sheep] at day 10, x 350). Bright punctate
staining in both photomicrographs is
due to autofluorescent intracytoplasmic
granules.
Table 2. Serum complement titrations in passive canine nephrotoxic glomeru1onephritis
Experiment Dog KFab
dose,
mg/kg
Control C'50H titrations
Day 1 Day 2 Day 3 Day 7 Day 10 Day 14
body wt
D 1
2
1.4
1.4
23
23
29
24
13.5
9.5
20
9.8
F 1
2
2.7
2.7
44
16
43
17
21
12.5
E 1
2
6.8
6.8
36
40
26
27
C'50H, complement titrations; KFab, kidney-fixing antibodies.
months later, after proteinuria and azotemia had
waned, all dogs were challenged with specific rabbit
antisheep IgG capable of reacting only with "planted"
nephrotoxic antibody on GBM. Specific antiglobulin
in doses from 3.1 to 31 mg reinduced immediate
proteinuria and azotemia.
Controls. Two normal dogs had widely scattered
focal deposition of host Ig in the glomerular mesan-
gium; no direct IF reactions were positive for canine
albumin, B1C or sheep and rabbit globulin. Dogs re-
ceiving 500 mg/kg of body wt of normal sheep globulin
failed to develop immediate proteinuria, and four of
six dogs developed mild proteinuria (66 to 200 mg/
24 hr) between experimental days 10 and 14. Direct IF
tests revealed no host or heterologous Ig in non-
proteinuric dogs, trace to I + diffuse mesangial stain-
ing for host and donor Ig and B1C in two animals, and
trace to 2+ diffuse granular deposits along glomerular
capillary walls of the other two.
Histopathologic and ultrastructural results. Standard
light microscopic and electron microscopic evaluations
done in the course of these studies were not the
primary focus of the experiments. Nonetheless, our
results were comparable to those reported in detail by
Movat, McGregor and Steiner [11] and by Wright,
Thompson and Cornwell [3].
Discussion
These experiments demonstrate the feasibility of
inducing nephrotoxic glomerulonephritis in canines
by active or passive immunization, and define the
immunological specificity of the mechanisms in-
volved By reason of logistical constraints, including
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time and intensity of immunological injury, passive
immunization with heterologous anticanine GBM
antisera appears the more practical mode of inducing
disease. Inasmuch as immediate, acute injury depends
directly on the amounts of nephrotoxic antibody
administered, immunological injury and consequent
physiological renal derangement can be induced more
precisely. Moreover, utilization of the persistence of
antibody binding to GBM over extended periods of
time permits re-excitation or deliberate exacerbation
of injury by administration of calculated amounts of
antiglobulin to the host animal.
Our data do not afford unique observations on
fundamental immunopathogenetic mechanisms caus-
ing renal injury. They do extend to the dog the
validity of experimental observations previously made
primarily in rats, rabbits and sheep [4]. These princi-
ples include the specificity of antibody binding to
canine GBM, dose-dependence in induction of
immediate glomerular injury, definition of heterolo-
gous and autologous phases of renal injury, comple-
ment participation in the immune injury and the
apparent nephritogenic comparability of rabbit and
sheep nephrotoxic antibodies.
Inferences derived from experimental work in
rodents would indicate that approximately 50% of the
glomerular surface area must be covered by nephro-
toxic antibodies to induce immediate proteinuria [12].
No direct measurements of glomerular surface area
are available from the dog, and data are inferential
regarding relationships between glomerular surface
area, kidney wt, total body wt and body surface area.
Dose ranges employed in experiments A, B and H
indicate that 700 g of KFab/kg of body wt caused
immediate proteinuria, whereas 50 and 270 g/kg of
body wt did not. Subject to numerous qualifications,
based on reported doses of KFab and weights of host
animals compared to those in our study [6, 12, 13],
the dog is more resistant to induction of passive
nephrotoxic glomerulonephritis than sheep and rab-
bits; susceptibility differences between dog and rat are
less certain.
In conclusion, passive nephrotoxic glomerulo-
nephritis is a practical and flexible model of diffuse,
immunologically mediated glomerulonephritis in dogs.
These studies confirm in the dog the specificity and
quantitative aspects of the immunopathogenetic
mechanisms studied in other species. In addition, our
data complement the range of observed interspecies
susceptibility to injury in experimental animals.
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